Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Income Quality Over TimeStable
Percentile Rank78
3Y CAGR+5.9%
5Y CAGR+26.7%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
+5.9%/yr
vs +18.4%/yr prior
5Y CAGR
+26.7%/yr
Recent deceleration
Acceleration
-12.5pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
20250.93+30.7%
20240.71-23.1%
20230.93+18.1%
20220.79-13.3%
20210.91+217.4%
20200.29-52.8%
20190.60+51.0%
20180.40-86.6%
20132.99-13.7%
20123.47-